Zinc complexation improves angiotensin II receptor type 1 blockade and in vivo antihypertensive activity of telmisartan

Angiotensin II receptor blockers were designed as therapeutic agents to block the binding site of the angiotensin II receptor type 1 (AT1R). The structure of telmisartan was modified by coordination to the biometal Zn(II), resulting in the compound ZnTelm. Its antihypertensive activity and cellular...

Full description

Saved in:
Bibliographic Details
Published in:Future medicinal chemistry 2021-01, Vol.13 (1), p.13-23
Main Authors: Martínez, Valeria R, Aguirre, María V, Todaro, Juan S, Lima, Augusto Martins, Stergiopulos, Nikolaos, Ferrer, Evelina G, Williams, Patricia Am
Format: Article
Language:English
Subjects:
Animals
Antihypertensive Agents - chemistry
Antihypertensive Agents - pharmacology
Arteries - metabolism
Calcium - metabolism
Cell Line
Coordination Complexes - chemistry
Disease Models, Animal
Humans
Hypertension - drug therapy
Male
Protein Binding
Rats
Rats, Wistar
Reactive Oxygen Species - metabolism
Receptor, Angiotensin, Type 1 - genetics
Receptor, Angiotensin, Type 1 - metabolism
Telmisartan - chemistry
Telmisartan - pharmacology
Transfection
Zinc - chemistry
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiotensin II receptor blockers were designed as therapeutic agents to block the binding site of the angiotensin II receptor type 1 (AT1R). The structure of telmisartan was modified by coordination to the biometal Zn(II), resulting in the compound ZnTelm. Its antihypertensive activity and cellular mechanisms in comparison to telmisartan were studied.  Compared with telmisartan, ZnTelm displayed stronger binding to AT1R (binding studies on AT1R-transfected human embryonic kidney cells) and a greater reduction of reactive oxygen species and cytosolic calcium concentration induced by angiotensin II. The antihypertensive activity of the complex (assessed in an N(G)-Nitro-L-arginine methyl ester-induced hypertension model) was significantly higher. ZnTelm also reduced hypertrophy in aortic artery rings and tubular collagen deposition. ZnTelm enhances the AT1R blockade and consequently its antihypertensive effect.
ISSN:1756-8919
1756-8927
DOI:10.4155/fmc-2020-0093